Prometheus Inc.   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: San Diego CA United States (1995)
Status: Acquired by Nestle (2011)

Organization Overview

First Clinical Trial
2005
NCT00113503
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Prometheus Biosciences | Prometheus Biosciences, Inc. | Prometheus Inc. | Prometheus Laboratories | Prometheus Labs | Prometheus Therapeutics and Diagnostics | Prometheus USA, Ltd. Co.